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Introduction
The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study reported that fenofibrate reduced the incidence of laser therapy for diabetic retinopathy (DR) in patients with type 2 diabetes. 1 However, in the FIELD study, the mechanism of this effect did not seem to be related to plasma lipid concentrations. Thus, it is important to explore further whether specific characteristics of plasma lipids, such as subtype or size, are risk factors for DR and other complications. 2 Compared with traditional measures of serum lipoproteins, nuclear magnetic resonance (NMR) spectroscopy offers new and efficient means of measuring lipoproteins. It quantifies them according to the amplitudes of spectral signals emitted by lipoprotein subclasses rather than cholesterol content, and provides more detailed information about lipoprotein subclasses. [3] [4] [5] We examined associations between NMR-measured lipoproteins and DR in type 2 diabetes participants in the Multi-Ethnic Study of Atherosclerosis (MESA), a population-based study in four racial/ethnic groups (whites, blacks, Hispanics and Chinese) from six US communities without prior cardiovascular disease at baseline. 6 Retinal photography immediately followed baseline examination. Of the 6,814 baseline participants, 6,147 had photographs which could be graded for DR, 7 defined as level 14 or higher following the modification of Airlie House Classification System. 8 Diabetes, defined as fasting glucose > 7.0 mmol/L (> 126 mg/dL), or use of insulin or oral hypoglycaemic agents, was present in 921 participants. Ethics approval was granted, and written informed consent obtained from each participant.
Standardised enzymatic methods were used to measure total cholesterol, high-density lipoprotein (HDL) BRIEF REPORT cholesterol, very-low-density lipoprotein (VLDL) cholesterol and triglycerides in fasting plasma. The Friedewald equation was used to estimate low-density lipoprotein (LDL)-cholesterol. Lipoprotein subclasses were measured on previously frozen plasma (-70°C) using NMR spectroscopy. 9, 10 The subclasses included: large HDL (8. 10 Logistic regression models were used to assess associations of lipoprotein subclass with DR, while adjusting for age, race/ethnicity, study centre, systolic blood pressure, use of antihypertensive and lipid-lowering medications, body mass index, smoking, diabetes duration, and glycosylated haemoglobin (HbA 1C ) levels. Statistical significance was taken at p<0.0025 (Bonferroni correction).
Of participants with diabetes, 30.2% had DR, 52.0% were male and 25.6% were on lipid-lowering medications. Participants with DR were more likely to be black or Hispanic, on diabetic medications, and to have a longer duration of diabetes, higher plasma glucose and systolic blood pressure levels than those without DR (data not shown).
Presence of DR was not associated with any of the NMRmeasured lipoproteins, either in all persons with diabetes, by gender (table 1) or by racial/ethnicity subgroups (data not shown). Supplementary analyses conducted in users and non-users of lipid-lowering medications showed no associations (data not shown).
There has been no previous study on whether lipoproteins 
